Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial.
- 2024-10-31
- RCT
- Journal of ovarian research 17(1)
- Anahid Shafie
- Ashraf Aleyasin
- Mojtaba Saffari
- Mojtaba Saedi
- Sahar Rostami
- Saeede Rezayi
- Seyed Danial Mohammadi
- Fardin Amidi
- PubMed: 39482765
- DOI: 10.1186/s13048-024-01537-7
- High evidence
- Clinical
After the intervention, the AST group exhibited a significant elevation in serum (P=0.013) and TAC (P=0.030), accompanied by a significant reduction in serum MDA (P=0.005).
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 12 mg/day